Dihydroxy Diketo Atorvastatin Impurity(1046118-44-8)
- Name: Dihydroxy Diketo Atorvastatin Impurity
- Synonyms:Dihydroxy Diketo Atorvastatin Impurity;1046118-44-8;2-[2-(4-fluorophenyl)-1-hydroxy-2-oxo-1-phenylethyl]-2-hydroxy-4-methyl-3-oxo-N-phenylpentanamide;SCHEMBL13287582;DTXSID60648381;KNFWPOXFDYWKMV-UHFFFAOYSA-N;FT-0667107;2-[2-(4-Fluorophenyl)-1-hydroxy-2-oxo-1-phenylethyl]-2-hydroxy-4-methyl-3-oxo-N-phenylpentanamide (non-preferred name)
- Molecular Formula:C26H24FNO5
- Molecular Weight:449.5
- CAS Registry Number:1046118-44-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1046118-44-8 Atorvastatin EP Impurity D (Atorvastatin USP Related Compound D)
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] 
Premium
SupplierTel:+86-173-20513646
Address:Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
- Contact Suppliers
CAS No.1046118-44-8 Dihydroxy Diketo Atorvastatin Impurity
Assay:97% Appearance:white crystalline powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States] 
Premium
SupplierTel:1-631-485-4226
Address:Ramsey Road
- Contact Suppliers
Other Product
- 1120214-98-3/7-Iodopyrido[2,3-b]pyrazine
- 40737-22-2/(5,8a-Dimethyl-1-methylidene-2,8-dioxo-3a,4,5,5a,9,9a-hexahydroazuleno[6,5-b]furan-9-yl) 3-methylbutanoate
- 1167056-19-0/5-Chloro-3-nitro-1H-pyrrolo[2,3-c]pyridine
- 1039985-93-7/N4-(2-methoxyethyl)pyridine-3,4-diamine
- 4630-24-4/3-(Ethoxycarbonyl)-9-methoxy-1,2,3,4,6,7-hexahydropyrido[2,1-a]isoquinolin-5-ium perchlorate
- 773130-02-2/3-[1-(Benzenesulfonyl)-1H-pyrrol-2-yl]prop-2-enoic acid
- 1119523-39-5/Ethyl 2-amino-3-nitro-4-(thiophen-2-yl)-5,6,7,8-tetrahydronaphthalene-1-carboxylate
- 1365968-55-3/tert-Butyl N-[1-(pyrazin-2-yl)piperidin-4-yl]methylcarbamate
- 1017782-56-7/tert-butyl 4-[6-chloro-5-(hydroxymethyl)-4-pyrimidinyl]tetrahydro-1(2H)-pyrazinecarboxylate
- 1408058-13-8/2-(4-Piperidyl)benzoxazole Hydrochloride
- 716358-75-7/4-Methoxy-3-[(propylamino)sulfonyl]benzoic acid
- 1260659-24-2/Methyl 5-(chlorosulfonyl)-1-ethyl-1H-pyrazole-3-carboxylate
- 898789-76-9/3-(2-Methylphenyl)-3'-trifluoromethylpropiophenone
- 1429665-03-1/(1,3-Benzoxazol-7-yl)boronic acid
- 518044-37-6/MAl-PEG6-t-butyl ester
- 1079300-06-3/3'-(3,4-Dihydroisoquinolin-1-yl)-N,N-diphenyl[1,1'-biphenyl]-4-amine
- 1231244-60-2/metazachlor OXA
- 104796-30-7/3,5-Dimethoxybenzofuran-2-carboxylic acid
- 1261903-49-4/5-(3-Fluoro-4-hydroxyphenyl)-2-methoxyphenol
- 1046118-44-8/Dihydroxy Diketo Atorvastatin Impurity
- 1333222-24-4/1-(5-(6-Methoxypyridazin-3-yl)pyridin-2-yl)ethanone
- 79729-70-7/(6-Hydroxy-7,7-dimethyl-17-methylidene-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-9-yl) hexadecanoate
- 474923-31-4/N-(dodecanoyl)-sphinganine-1-phosphocholine
- 5898-38-4/3-(4-Bromophenyl)[1,3]thiazolo[3,2-a]pyridin-4-ium perchlorate
- 1089339-61-6/N-Boc-desmethoxy Gatifloxacin
- 111108-40-8/2-Amino-4,5-dimethylnicotinic acid
- 1261897-84-0/5-(3,5-Dicarboxyphenyl)-3-trifluoromethylphenol
- 83192-85-2/N,N-Dimethyl-4-(4-methylphenyl)-4-oxo-2-butenamide
- 898755-58-3/Ethyl 6-(2-(azetidin-1-ylmethyl)phenyl)-6-oxohexanoate
- 380394-88-7/5,6,7,8-Tetrahydro-1,8-Naphthyridin-2-butylamine